Numelvi 4.8mg (S) - 90 Tablets
MSD |
219141

Numelvi 4.8mg (S) - 90 Tablets

Prescription Product

This is a Schedule 4 (S4) Controlled Substance. Supply is strictly regulated under Australian law. Valid authorisation is required to purchase this product.

Enquire today to create an account

Register
Description
Numelvi® (atinvicitinib) is the first and only second-generation JAK1 inhibitor for dogs indicated for the symptomatic treatment of pruritus, inflammation and clinical signs associated with allergic dermatitis, including atopic dermatitis . It is suitable for dogs and puppies from 6 months of age and 2 kg body weight.

Active: Atinvicitinib (4.8mg)

Pack Size: 90 Tablets
Additional Information
[Zebravet_Files]:
[Zebravet_Files]
Classification:
S4
Categorisation:
Prescription
Species:
Dog
Ingredients:
ATINVICITINIB 4.8 MG TABS